Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? (2011)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; CARRILHO, FLAIR JOSÉ - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM
- Unidade: FM
- DOI: 10.1111/j.1478-3231.2010.02370.x
- Subjects: BIOMARCADORES; IMUNOHISTOQUÍMICA; FÍGADO GORDUROSO; HEPATOPATIAS (IMUNOLOGIA); APOPTOSE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Liver international
- ISSN: 0022-510X
- Volume/Número/Paginação/Ano: v. 31, n. 3, p. 377-385, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
STEFANO, José T et al. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?. Liver international, v. 31, n. 3, p. 377-385, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1478-3231.2010.02370.x. Acesso em: 19 abr. 2024. -
APA
Stefano, J. T., Oliveira, C. P. M. S. de, Giannella, M. L. C. C., Soares, I. C., Kubrusly, M. S., Privato, M. B., et al. (2011). Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Liver international, 31( 3), 377-385. doi:10.1111/j.1478-3231.2010.02370.x -
NLM
Stefano JT, Oliveira CPMS de, Giannella MLCC, Soares IC, Kubrusly MS, Privato MB, Mello ES de, Lima VMR de, Carrilho FJ, Alves VAF. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? [Internet]. Liver international. 2011 ; 31( 3): 377-385.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1111/j.1478-3231.2010.02370.x -
Vancouver
Stefano JT, Oliveira CPMS de, Giannella MLCC, Soares IC, Kubrusly MS, Privato MB, Mello ES de, Lima VMR de, Carrilho FJ, Alves VAF. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? [Internet]. Liver international. 2011 ; 31( 3): 377-385.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1111/j.1478-3231.2010.02370.x - Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
- Nonalcoholic steatohepatitis in ob/ob mice treated with yo jyo hen shi ko: effects on peroxisome proliferator-activated receptors nad microsomal triglyceride transfer protein
- Survivin expression patterns could reflect different roles in hepatocarcinogenesis, especially in non-alcoholic fatty liver disease-related hepatocellular carcinoma [Carta]
- Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C
- Nonalcoholic Steatohepatitis (NASH) in OB/OB Mice Treated with Yo Jyo Hen Shi Ko (YHK): Effects on Peroxisome Proliferator-Activated Receptors (PPARs) and Microsomal Triglyceride Transfer Protein (MTP)
- Protective effect of S-Nitroso-N-Acetylcysteine (SNAC) in nonalcoholic steatophepatitis (NASH) in OB/OB mice: downregulation of genes belonging to mitochondrial fatty acids oxidation pathways
- Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice
- Modulation of hepatic microsomal triglyceride transfer protien induced by s-nitroso-n-acetylcysteine in ob/ob mice
- Esteato-hepatite não alcoólica e doença hepática alcoólica
- S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro
Informações sobre o DOI: 10.1111/j.1478-3231.2010.02370.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
